Overexpression of indoleamine 2,3-dioxygenase correlates with regulatory T cell phenotype in acute myeloid leukemia patients with normal karyotype

BACKGROUND: Production of immunosuppressive enzymes such as indoleamine 2,3-dioxygenase (IDO) is one of the strategies employed by hematologic malignancies, including acute myeloid leukemia (AML), to circumvent immune surveillance. Moreover, IDO has the ability to convert CD4(+)CD25(−) conventional...

Descripción completa

Detalles Bibliográficos
Autores principales: Arandi, Nargess, Ramzi, Mani, Safaei, Fatemeh, Monabati, Ahmad
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Society of Hematology; Korean Society of Blood and Marrow Transplantation; Korean Society of Pediatric Hematology-Oncology; Korean Society on Thrombosis and Hemostasis 2018
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6300669/
https://www.ncbi.nlm.nih.gov/pubmed/30588466
http://dx.doi.org/10.5045/br.2018.53.4.294

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6300669/
https://www.ncbi.nlm.nih.gov/pubmed/30588466
http://dx.doi.org/10.5045/br.2018.53.4.294

Ejemplares similares